National Programs, Drug Discovery, and Data Challenges: Regional and End-User Dynamics in the AI in Genomics Market

The AI in genomics market is expanding as hospitals, research institutes, and biopharmaceutical organizations look for faster ways to turn genomic data into actionable insight. Polaris Market Research estimates the market at USD 1.45 billion in 2026, compared with USD 1.04 billion in 2025, and projects it to reach USD 21.08 billion by 2034 at a CAGR of 39.74% during 2026–2034. Beyond the headline figures, end-user demand, applications, and data challenges shape the opportunities.

End-User Demand: Research Institutes and Hospitals

Research institutes dominated the end-user segment with a 34.0% share in 2025 owing to extensive use of genomic analysis technologies in academic and clinical research. Growing investments in genomics research and increasing collaboration with biotechnology companies are supporting segment growth. Hospitals, meanwhile, are projected to grow at the fastest end-user CAGR of 40.3% during the forecast period, driven by the increasing integration of genomic testing into clinical workflows.

National Programs and Research Initiatives

Population genomics is projected to be the fastest-growing application, at a CAGR of 40.8% during the forecast period. Increasing government-funded genomic research programs and expanding national sequencing initiatives are contributing to its rapid development.

Industry initiatives reinforce this direction. In June 2026, the American Society of Human Genetics launched an AI Initiative to foster responsible use of artificial intelligence in human genetics and genomics research. In the same month, Google DeepMind, Google.org, and the Wellcome Sanger Institute formed a genomics consortium to develop AI-driven genomics research. Such efforts show how population genomics is attracting collaboration across research and technology organizations.

Drug Discovery and Multi-Omics Opportunities

Advanced artificial intelligence applications are enabling scientists to discover genetic targets and make more accurate predictions about treatment outcomes, improving efficiency in the drug discovery process. As a result, AI-driven drug discovery is among the significant opportunities identified for market players, alongside regenerative medicine and the use of organoids in research. In June 2026, Merck and Protillion Biosciences announced a collaboration on drug discovery using artificial intelligence.

Commercialization of organoids and increasing multi-omics research are also expected to raise demand for genomics platforms. On the technology side, multi-omics integration, which combines genomic, proteomic, and transcriptomic datasets, is in a growing deployment stage and enhances research outcomes.

Data Challenges and Barriers to Entry

Genomic data contains personal patient information that must be stored and processed through secure systems. For this reason, genomic data privacy and compliance requirements continue to hinder market development. Differences between national regulatory systems create an extra challenge for technology vendors, while high integration costs and a lack of qualified specialists limit adoption among smaller organizations. Entry barriers include high computation needs, complex integration procedures, clinical validation requirements, and specialized expertise in both AI and genomics.

At the same time, demand is rising for integrated platforms that support genomic data management for large datasets across multiple research environments. Enhanced data governance frameworks, now in mainstream adoption, help organizations support regulatory compliance.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/ai-in-genomics-market 

Regional Perspective

North America dominated with a 43.0% share in 2025 owing to advanced healthcare facilities, adoption of genomic technologies, and research funding, with the U.S. as the largest contributor. Europe held a 26.0% share in 2025, supported by rising genomic research activity and favorable healthcare policies in countries such as Germany, the UK, France, and the Netherlands.

Asia Pacific is expected to grow at a CAGR of 41.5%, as China, Japan, India, South Korea, Hong Kong, and Australia increase investments in genomic research and healthcare innovation. In December 2025, Gleneagles Hong Kong launched an AI-powered longevity program that uses genomic and clinical data to deliver personalized preventive healthcare. In the Middle East & Africa, BGI Genomics introduced its i99 AI platform in September 2025 to help transform healthcare under Saudi Arabia's Vision 2030.

Key Players to Watch

Across the AI in genomics market, the report's key player list includes DNAnexus, Fabric Genomics, Google DeepMind, IBM, Illumina, Microsoft, NVIDIA, Oracle, SAP, SOPHiA GENETICS, Tempus AI, and Thermo Fisher Scientific. DNAnexus is positioned around genomic data management, Fabric Genomics around clinical genomics interpretation, and NVIDIA around AI computing infrastructure. Matching these strengths to buyer priorities such as validation, compliance, and scalable data handling can help stakeholders shortlist partners

Conclusion

The AI in Genomics Market is expected to witness significant growth as artificial intelligence transforms genomic research, disease diagnosis, and precision medicine. Increasing demand for personalized healthcare and advancements in next-generation sequencing technologies are driving market expansion. AI-powered platforms enable faster analysis of complex genetic datasets, improving research efficiency and clinical decision-making. Growing investments in biotechnology and genomic research further support market development. Despite challenges related to data privacy and implementation costs, technological innovations are creating new opportunities. The market is anticipated to play a crucial role in advancing personalized treatments and genomic discoveries.

More Trending Latest Reports By Polaris Market Research:

Trauma Products Market

Lithium-Ion Battery Anode Market

Data Center Market

T4 DNA Ligase Market

Lithium-Ion Battery Anode Market

Muscle Stimulator Market

Multideck Refrigerated Display Cases Market

Exploring Benefits and Trends in Fencing Market

Data Diode Market